title: Chronic intermittent hypoxia induces atherosclerosis by NF-κB-dependent mechanisms.
abstract: Chronic intermittent hypoxia (CIH) causes atherosclerosis in mice fed a high cholesterol diet (HCD). The mechanisms by which CIH promotes atherosclerosis are incompletely understood. This study defined the mechanistic role of NF-κB pathway in CIH+HCD induced atherosclerosis. Wild type (WT) and mice deficient in the p50 subunit of NF-κB (p50-KO) were fed normal chow diet (ND) or HCD, and exposed to sham or CIH. Atherosclerotic lesions on the en face aortic preparation and cross-sections of aortic root were examined. In WT mice, neither CIH nor HCD exposure alone caused, but CIH+HCD caused evident atherosclerotic lesions on both preparations after 20weeks of exposure. WT mice on ND and exposed to CIH for 35.6weeks did not develop atherosclerotic lesions. P50 gene deletion diminished CIH+HCD induced NF-κB activation and abolished CIH+HCD induced atherosclerosis. P50 gene deletion inhibited vascular wall inflammation, reduced hepatic TNF-α level, attenuated the elevation in serum cholesterol level and diminished macrophage foam cell formation induced by CIH+HCD exposure. These results demonstrate that inhibition of NF-κB activation abrogates the activation of three major atherogenic mechanisms associated with an abolition of CIH+HCD induced atherosclerosis. NF-κB may be a central common pathway through which CIH+HCD exposure activates multiple atherogenic mechanisms, leading to atherosclerosis.
authors: Centers for Heart and Lung Research and Pulmonary, Critical Care and Sleep Medicine, the Feinstein Institute for Medical Research, Manhasset, NY, USA.
authors: D
authors: D
authors: Song
authors: G
authors: G
authors: Fang
authors: S-Z
authors: SZ
authors: Mao
authors: X
authors: X
authors: Ye
authors: G
authors: G
authors: Liu
authors: Y
authors: Y
authors: Gong
authors: S F
authors: SF
authors: Liu
mesh_terms: D000818:Animals; D001011:Aorta / Q000378:metabolism / Q000473:pathology; D050197:Atherosclerosis / Q000378:metabolism*; D015687:Cell Hypoxia; D002784:Cholesterol / Q000008:administration & dosage / Q000097:blood; D004032:Diet; D008055:Lipids / Q000097:blood; D008099:Liver / Q000378:metabolism / Q000473:pathology; D008264:Macrophages / Q000378:metabolism / Q000473:pathology; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D052002:NF-kappa B p50 Subunit / Q000235:genetics / Q000378:metabolism*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
chemical_list: D008055:Lipids; D052002:NF-kappa B p50 Subunit; D014409:Tumor Necrosis Factor-alpha; D002784:Cholesterol